

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.28018755 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.81121664 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.81121664 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.55672808 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.39759887 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.39759887 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.23601249 |
| 8 | microglial cell activation (GO:0001774) | 4.98669072 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.88280529 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.88280529 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.76094421 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.76094421 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.76094421 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.76094421 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.76094421 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.76094421 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.64881495 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.62221094 |
| 19 | hepatocyte apoptotic process (GO:0097284) | 4.54913952 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 4.54138899 |
| 21 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.53727299 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.47189068 |
| 23 | fatty acid elongation (GO:0030497) | 4.18746718 |
| 24 | positive thymic T cell selection (GO:0045059) | 4.18011700 |
| 25 | positive T cell selection (GO:0043368) | 4.15875732 |
| 26 | aromatic amino acid family catabolic process (GO:0009074) | 4.12991423 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 4.10141092 |
| 28 | glyoxylate metabolic process (GO:0046487) | 4.09010688 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.08283593 |
| 30 | cellular extravasation (GO:0045123) | 4.04747918 |
| 31 | central nervous system myelination (GO:0022010) | 4.02675372 |
| 32 | axon ensheathment in central nervous system (GO:0032291) | 4.02675372 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.99745240 |
| 34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.93999009 |
| 35 | negative T cell selection (GO:0043383) | 3.92902630 |
| 36 | B cell receptor signaling pathway (GO:0050853) | 3.88205801 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.86779802 |
| 38 | cysteine metabolic process (GO:0006534) | 3.86304597 |
| 39 | positive regulation of granulocyte differentiation (GO:0030854) | 3.85953982 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.85892294 |
| 41 | macrophage activation (GO:0042116) | 3.84918599 |
| 42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84881710 |
| 43 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.84409145 |
| 44 | detection of other organism (GO:0098543) | 3.83531058 |
| 45 | detection of external biotic stimulus (GO:0098581) | 3.82697370 |
| 46 | histone H3-K36 demethylation (GO:0070544) | 3.71362869 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68857624 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.68749597 |
| 49 | neutrophil mediated immunity (GO:0002446) | 3.66888038 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.56662016 |
| 51 | response to methylmercury (GO:0051597) | 3.54686577 |
| 52 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.53803275 |
| 53 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.52384728 |
| 54 | regulation of necroptotic process (GO:0060544) | 3.52182075 |
| 55 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.51736016 |
| 56 | bile acid biosynthetic process (GO:0006699) | 3.51678877 |
| 57 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.49861165 |
| 58 | response to interleukin-15 (GO:0070672) | 3.47793700 |
| 59 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.45885384 |
| 60 | positive regulation of receptor recycling (GO:0001921) | 3.44359570 |
| 61 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.42285243 |
| 62 | sulfur amino acid catabolic process (GO:0000098) | 3.41952019 |
| 63 | detection of bacterium (GO:0016045) | 3.41079178 |
| 64 | cholesterol biosynthetic process (GO:0006695) | 3.38994249 |
| 65 | very long-chain fatty acid metabolic process (GO:0000038) | 3.38268784 |
| 66 | myeloid leukocyte mediated immunity (GO:0002444) | 3.37430118 |
| 67 | erythrocyte development (GO:0048821) | 3.37114662 |
| 68 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.37038704 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.35525671 |
| 70 | response to host immune response (GO:0052572) | 3.35525671 |
| 71 | coenzyme catabolic process (GO:0009109) | 3.34648844 |
| 72 | acetyl-CoA metabolic process (GO:0006084) | 3.32351819 |
| 73 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.30840649 |
| 74 | protein carboxylation (GO:0018214) | 3.30840649 |
| 75 | activated T cell proliferation (GO:0050798) | 3.29891446 |
| 76 | regulation of beta-amyloid formation (GO:1902003) | 3.28294258 |
| 77 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27726520 |
| 78 | detection of biotic stimulus (GO:0009595) | 3.27013532 |
| 79 | regulation of platelet aggregation (GO:0090330) | 3.25878124 |
| 80 | T cell selection (GO:0045058) | 3.24644694 |
| 81 | oxygen transport (GO:0015671) | 3.23614893 |
| 82 | cellular ketone body metabolic process (GO:0046950) | 3.22391227 |
| 83 | negative regulation of interleukin-12 production (GO:0032695) | 3.21815184 |
| 84 | thioester biosynthetic process (GO:0035384) | 3.20643356 |
| 85 | acyl-CoA biosynthetic process (GO:0071616) | 3.20643356 |
| 86 | drug transmembrane transport (GO:0006855) | 3.20611798 |
| 87 | short-chain fatty acid metabolic process (GO:0046459) | 3.19612366 |
| 88 | regulation of B cell differentiation (GO:0045577) | 3.19291761 |
| 89 | tyrosine metabolic process (GO:0006570) | 3.18931397 |
| 90 | lysine catabolic process (GO:0006554) | 3.17311909 |
| 91 | lysine metabolic process (GO:0006553) | 3.17311909 |
| 92 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.14884687 |
| 93 | leukocyte aggregation (GO:0070486) | 3.14838624 |
| 94 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.13566950 |
| 95 | response to host (GO:0075136) | 3.13566950 |
| 96 | response to host defenses (GO:0052200) | 3.13566950 |
| 97 | bile acid metabolic process (GO:0008206) | 3.12514702 |
| 98 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.10902923 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 3.09646667 |
| 100 | myeloid cell activation involved in immune response (GO:0002275) | 3.06469902 |
| 101 | heme transport (GO:0015886) | 3.06034958 |
| 102 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.06028655 |
| 103 | positive regulation of B cell differentiation (GO:0045579) | 3.05047066 |
| 104 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.04670198 |
| 105 | myeloid cell development (GO:0061515) | 3.04350383 |
| 106 | neutrophil activation (GO:0042119) | 3.03874874 |
| 107 | respiratory burst (GO:0045730) | 3.03315560 |
| 108 | hemoglobin metabolic process (GO:0020027) | 3.02499986 |
| 109 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.02300208 |
| 110 | high-density lipoprotein particle remodeling (GO:0034375) | 2.99063094 |
| 111 | glutamate metabolic process (GO:0006536) | 2.98758242 |
| 112 | thymic T cell selection (GO:0045061) | 2.98590309 |
| 113 | tryptophan catabolic process (GO:0006569) | 2.98149591 |
| 114 | indole-containing compound catabolic process (GO:0042436) | 2.98149591 |
| 115 | indolalkylamine catabolic process (GO:0046218) | 2.98149591 |
| 116 | T cell migration (GO:0072678) | 2.97497775 |
| 117 | complement activation, alternative pathway (GO:0006957) | 2.96382226 |
| 118 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.95806453 |
| 119 | kynurenine metabolic process (GO:0070189) | 2.94867269 |
| 120 | tryptophan metabolic process (GO:0006568) | 2.93698050 |
| 121 | sterol biosynthetic process (GO:0016126) | 2.93190766 |
| 122 | intestinal cholesterol absorption (GO:0030299) | 2.92945164 |
| 123 | regulation of granulocyte differentiation (GO:0030852) | 2.91642071 |
| 124 | cellular response to interleukin-15 (GO:0071350) | 2.91334580 |
| 125 | negative regulation of B cell proliferation (GO:0030889) | 2.91207217 |
| 126 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.90673061 |
| 127 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.89078736 |
| 128 | aromatic amino acid family metabolic process (GO:0009072) | 2.88583625 |
| 129 | aspartate family amino acid catabolic process (GO:0009068) | 2.87281381 |
| 130 | negative regulation of fibrinolysis (GO:0051918) | 2.86644934 |
| 131 | ensheathment of neurons (GO:0007272) | 2.85598533 |
| 132 | axon ensheathment (GO:0008366) | 2.85598533 |
| 133 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84968025 |
| 134 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.83438488 |
| 135 | myelination (GO:0042552) | 2.83196874 |
| 136 | homocysteine metabolic process (GO:0050667) | 2.82517721 |
| 137 | cholesterol efflux (GO:0033344) | 2.82169307 |
| 138 | negative regulation of B cell mediated immunity (GO:0002713) | 2.81614055 |
| 139 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.81614055 |
| 140 | ketone body metabolic process (GO:1902224) | 2.81389136 |
| 141 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.81070815 |
| 142 | cellular modified amino acid catabolic process (GO:0042219) | 2.80534958 |
| 143 | reverse cholesterol transport (GO:0043691) | 2.79227386 |
| 144 | negative regulation of adaptive immune response (GO:0002820) | 2.77026530 |
| 145 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.76605319 |
| 146 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.76605319 |
| 147 | ethanol oxidation (GO:0006069) | 2.76100321 |
| 148 | protein K11-linked deubiquitination (GO:0035871) | 2.76053856 |
| 149 | macroautophagy (GO:0016236) | 2.75355131 |
| 150 | response to peptidoglycan (GO:0032494) | 2.75038894 |
| 151 | acylglycerol homeostasis (GO:0055090) | 2.74446632 |
| 152 | triglyceride homeostasis (GO:0070328) | 2.74446632 |
| 153 | response to mercury ion (GO:0046689) | 2.74251309 |
| 154 | regulation of fibrinolysis (GO:0051917) | 2.74213410 |
| 155 | thioester metabolic process (GO:0035383) | 2.73875247 |
| 156 | acyl-CoA metabolic process (GO:0006637) | 2.73875247 |
| 157 | cellular response to epinephrine stimulus (GO:0071872) | 2.72992880 |
| 158 | regulation of triglyceride catabolic process (GO:0010896) | 2.72759374 |
| 159 | granulocyte activation (GO:0036230) | 2.72349566 |
| 160 | regulation of cellular amide metabolic process (GO:0034248) | 2.72215629 |
| 161 | drug catabolic process (GO:0042737) | 2.71998710 |
| 162 | fatty acid beta-oxidation (GO:0006635) | 2.71981863 |
| 163 | urea metabolic process (GO:0019627) | 2.71815986 |
| 164 | urea cycle (GO:0000050) | 2.71815986 |
| 165 | regulation of protein activation cascade (GO:2000257) | 2.70910992 |
| 166 | regulation of mast cell degranulation (GO:0043304) | 2.70545063 |
| 167 | regulation of cholesterol homeostasis (GO:2000188) | 2.70222933 |
| 168 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.70073177 |
| 169 | alpha-amino acid catabolic process (GO:1901606) | 2.68753067 |
| 170 | megakaryocyte development (GO:0035855) | 2.68650795 |
| 171 | gas transport (GO:0015669) | 2.68585774 |
| 172 | fatty acid oxidation (GO:0019395) | 2.67523053 |
| 173 | cofactor catabolic process (GO:0051187) | 2.67202490 |
| 174 | creatine metabolic process (GO:0006600) | 2.66889783 |
| 175 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.65809448 |
| 176 | negative regulation of glial cell proliferation (GO:0060253) | 2.65621706 |
| 177 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.65447339 |
| 178 | fatty acid catabolic process (GO:0009062) | 2.64604424 |
| 179 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.64300376 |
| 180 | cellular amino acid catabolic process (GO:0009063) | 2.64061582 |
| 181 | dendritic cell migration (GO:0036336) | 2.63792690 |
| 182 | regulation of cholesterol metabolic process (GO:0090181) | 2.63167647 |
| 183 | cholesterol metabolic process (GO:0008203) | 2.63035614 |
| 184 | lipid oxidation (GO:0034440) | 2.62201916 |
| 185 | import into cell (GO:0098657) | 2.59380462 |
| 186 | protein-lipid complex assembly (GO:0065005) | 2.58847120 |
| 187 | plasma lipoprotein particle assembly (GO:0034377) | 2.57510758 |
| 188 | monocarboxylic acid catabolic process (GO:0072329) | 2.56534694 |
| 189 | response to lipoprotein particle (GO:0055094) | 2.56135973 |
| 190 | myelin maintenance (GO:0043217) | 2.56116975 |
| 191 | regulation of complement activation (GO:0030449) | 2.55260599 |
| 192 | nitrogen cycle metabolic process (GO:0071941) | 2.51267894 |
| 193 | negative regulation of lipase activity (GO:0060192) | 2.50629993 |
| 194 | amino-acid betaine metabolic process (GO:0006577) | 2.50101314 |
| 195 | protein-lipid complex remodeling (GO:0034368) | 2.49764217 |
| 196 | macromolecular complex remodeling (GO:0034367) | 2.49764217 |
| 197 | plasma lipoprotein particle remodeling (GO:0034369) | 2.49764217 |
| 198 | cholesterol homeostasis (GO:0042632) | 2.47505722 |
| 199 | sterol homeostasis (GO:0055092) | 2.45302537 |
| 200 | phospholipid efflux (GO:0033700) | 2.45250695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.42250299 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.69954778 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.53041822 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.33338473 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.99385412 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.60883100 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.51058418 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.30481861 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.25736869 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.08746466 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03721278 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.95830310 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.95341109 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.90846919 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.84547974 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.84405395 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.82602568 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.78626887 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.67521745 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64514570 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.58302846 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.45384303 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.41382711 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.37210393 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.33124205 |
| 26 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.29516511 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23021717 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.20067976 |
| 29 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.14774310 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 2.12256427 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.03907375 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.96811839 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96679618 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95782737 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93634172 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.89192505 |
| 37 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.83608319 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.82242602 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.81304014 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77851277 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.66956922 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64287231 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63862501 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63499290 |
| 45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62266932 |
| 46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.61293714 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61107864 |
| 48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.60070445 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57765242 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57421975 |
| 51 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.54906729 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54896381 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54701279 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.53342359 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50367106 |
| 56 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50243386 |
| 57 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.48292880 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47894049 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46682528 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46264521 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43285551 |
| 62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42622735 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.42310119 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.42310119 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40621420 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40315965 |
| 67 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.40263022 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39708177 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.38661059 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37029289 |
| 71 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.35196512 |
| 72 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.34518726 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33824747 |
| 74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.33204436 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32785711 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32233637 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30868774 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30340974 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30080441 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29307037 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29007866 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27954557 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27719318 |
| 84 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.26807224 |
| 85 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.22994845 |
| 86 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22782535 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21699908 |
| 88 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18001303 |
| 89 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17987656 |
| 90 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.16429093 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15996659 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15641602 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 1.14426884 |
| 94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13537509 |
| 95 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.12242686 |
| 96 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.12242686 |
| 97 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11862828 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11594459 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11256308 |
| 100 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09423254 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08744885 |
| 102 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.08344559 |
| 103 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07480451 |
| 104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05576715 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05381365 |
| 106 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05281873 |
| 107 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.05264998 |
| 108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05131331 |
| 109 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04303197 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03918393 |
| 111 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03815475 |
| 112 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.03728670 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03244415 |
| 114 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03213210 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02925588 |
| 116 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02833231 |
| 117 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.01800551 |
| 118 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.01199766 |
| 119 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00561404 |
| 120 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00316283 |
| 121 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99657189 |
| 122 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98699804 |
| 123 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.98610546 |
| 124 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.98435652 |
| 125 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98034064 |
| 126 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97302312 |
| 127 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.94764924 |
| 128 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94645254 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94440356 |
| 130 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94037645 |
| 131 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.93271117 |
| 132 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92918959 |
| 133 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92325909 |
| 134 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92253004 |
| 135 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92224436 |
| 136 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91662625 |
| 137 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.90918759 |
| 138 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90404745 |
| 139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89617282 |
| 140 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87703785 |
| 141 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.86740234 |
| 142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85991891 |
| 143 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.85511832 |
| 144 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.85233720 |
| 145 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.85186691 |
| 146 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.84998986 |
| 147 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84378760 |
| 148 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84274520 |
| 149 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83436813 |
| 150 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.82907702 |
| 151 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.82633969 |
| 152 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82576040 |
| 153 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.82567771 |
| 154 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82251753 |
| 155 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81908648 |
| 156 | STAT3_23295773_ChIP-Seq_U87_Human | 0.81152056 |
| 157 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80971690 |
| 158 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80644726 |
| 159 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.80255393 |
| 160 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80074054 |
| 161 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.79787444 |
| 162 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79664855 |
| 163 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.78793476 |
| 164 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78761583 |
| 165 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78319139 |
| 166 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78022371 |
| 167 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77337887 |
| 168 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75032516 |
| 169 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74081459 |
| 170 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.74044035 |
| 171 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.73669152 |
| 172 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.73213106 |
| 173 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.73034549 |
| 174 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.72911175 |
| 175 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.72911175 |
| 176 | CJUN_26792858_Chip-Seq_BT549_Human | 0.72053749 |
| 177 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71979669 |
| 178 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71868969 |
| 179 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.71808048 |
| 180 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.71744129 |
| 181 | KDM2B_26808549_Chip-Seq_K562_Human | 0.71615956 |
| 182 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.70413813 |
| 183 | GATA3_26560356_Chip-Seq_TH1_Human | 0.69666545 |
| 184 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.69011651 |
| 185 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65751492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.84345358 |
| 2 | MP0005360_urolithiasis | 5.14961181 |
| 3 | MP0008260_abnormal_autophagy | 4.59797767 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.06672564 |
| 5 | MP0005365_abnormal_bile_salt | 3.99893610 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.99123430 |
| 7 | MP0003195_calcinosis | 3.68003446 |
| 8 | MP0003724_increased_susceptibility_to | 3.49660412 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.31044677 |
| 10 | MP0003303_peritoneal_inflammation | 3.30510089 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.99856267 |
| 12 | MP0003252_abnormal_bile_duct | 2.92712521 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.65407647 |
| 14 | MP0005083_abnormal_biliary_tract | 2.64801157 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.64686163 |
| 16 | MP0004043_abnormal_pH_regulation | 2.59401274 |
| 17 | MP0003436_decreased_susceptibility_to | 2.55741389 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.52874944 |
| 19 | MP0000920_abnormal_myelination | 2.45995647 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.44532883 |
| 21 | MP0000685_abnormal_immune_system | 2.43136275 |
| 22 | MP0001800_abnormal_humoral_immune | 2.41644914 |
| 23 | MP0003690_abnormal_glial_cell | 2.41438186 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.34632210 |
| 25 | MP0005332_abnormal_amino_acid | 2.20755926 |
| 26 | MP0002419_abnormal_innate_immunity | 2.19124304 |
| 27 | MP0009840_abnormal_foam_cell | 2.18466728 |
| 28 | MP0004381_abnormal_hair_follicle | 2.14090415 |
| 29 | MP0005025_abnormal_response_to | 2.08239790 |
| 30 | MP0000015_abnormal_ear_pigmentation | 2.05515827 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.99706150 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.97770294 |
| 33 | MP0001819_abnormal_immune_cell | 1.96619947 |
| 34 | MP0002398_abnormal_bone_marrow | 1.95174312 |
| 35 | MP0002723_abnormal_immune_serum | 1.92757356 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.91416702 |
| 37 | MP0004883_abnormal_blood_vessel | 1.88174485 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.85940701 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.85729194 |
| 40 | MP0001790_abnormal_immune_system | 1.85257848 |
| 41 | MP0005387_immune_system_phenotype | 1.85257848 |
| 42 | MP0003329_amyloid_beta_deposits | 1.83496728 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.83285284 |
| 44 | MP0003787_abnormal_imprinting | 1.83005673 |
| 45 | MP0005671_abnormal_response_to | 1.81077723 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.79777062 |
| 47 | MP0002405_respiratory_system_inflammati | 1.79497870 |
| 48 | MP0003868_abnormal_feces_composition | 1.78266573 |
| 49 | MP0009785_altered_susceptibility_to | 1.73262640 |
| 50 | MP0003828_pulmonary_edema | 1.72905614 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.69743822 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.68788586 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.67474211 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.67252617 |
| 55 | MP0000716_abnormal_immune_system | 1.65819693 |
| 56 | MP0002722_abnormal_immune_system | 1.64537454 |
| 57 | MP0005310_abnormal_salivary_gland | 1.62912204 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.58307343 |
| 59 | MP0003866_abnormal_defecation | 1.55310036 |
| 60 | MP0003221_abnormal_cardiomyocyte_apopto | 1.52597875 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.52409714 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.48798642 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.48798642 |
| 64 | MP0004885_abnormal_endolymph | 1.48424609 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.47563955 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.46904119 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.45885187 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 1.44453271 |
| 69 | MP0004947_skin_inflammation | 1.44069153 |
| 70 | MP0000604_amyloidosis | 1.41962053 |
| 71 | MP0008057_abnormal_DNA_replication | 1.41015088 |
| 72 | MP0002429_abnormal_blood_cell | 1.40678585 |
| 73 | MP0002332_abnormal_exercise_endurance | 1.38382671 |
| 74 | MP0006082_CNS_inflammation | 1.32447239 |
| 75 | MP0000609_abnormal_liver_physiology | 1.30529710 |
| 76 | MP0004147_increased_porphyrin_level | 1.27722780 |
| 77 | MP0001845_abnormal_inflammatory_respons | 1.27596272 |
| 78 | MP0000462_abnormal_digestive_system | 1.25505271 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24911947 |
| 80 | MP0002132_abnormal_respiratory_system | 1.23832030 |
| 81 | MP0005451_abnormal_body_composition | 1.22812585 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.21964532 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 1.21055001 |
| 84 | MP0004484_altered_response_of | 1.20687585 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 1.19803438 |
| 86 | MP0003634_abnormal_glial_cell | 1.19436194 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 1.19168242 |
| 88 | MP0004130_abnormal_muscle_cell | 1.19032903 |
| 89 | MP0005164_abnormal_response_to | 1.18835632 |
| 90 | MP0001661_extended_life_span | 1.18240055 |
| 91 | MP0008438_abnormal_cutaneous_collagen | 1.16732449 |
| 92 | MP0001851_eye_inflammation | 1.16572106 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 1.10970991 |
| 94 | MP0009333_abnormal_splenocyte_physiolog | 1.09474404 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 1.08835235 |
| 96 | MP0001533_abnormal_skeleton_physiology | 1.08812423 |
| 97 | MP0000858_altered_metastatic_potential | 1.07689010 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 1.07018099 |
| 99 | MP0003091_abnormal_cell_migration | 1.03984696 |
| 100 | MP0009278_abnormal_bone_marrow | 1.02788520 |
| 101 | MP0001756_abnormal_urination | 1.02234190 |
| 102 | MP0005408_hypopigmentation | 1.01792340 |
| 103 | MP0002006_tumorigenesis | 1.01294974 |
| 104 | MP0001765_abnormal_ion_homeostasis | 1.00939596 |
| 105 | MP0004270_analgesia | 1.00668950 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.98825408 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.98020982 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.97893095 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.95880237 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.95827626 |
| 111 | MP0009764_decreased_sensitivity_to | 0.94691810 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.92143399 |
| 113 | MP0005535_abnormal_body_temperature | 0.92138093 |
| 114 | MP0003283_abnormal_digestive_organ | 0.91993110 |
| 115 | MP0008877_abnormal_DNA_methylation | 0.91212399 |
| 116 | MP0002896_abnormal_bone_mineralization | 0.90903608 |
| 117 | MP0008995_early_reproductive_senescence | 0.89701743 |
| 118 | MP0008469_abnormal_protein_level | 0.88717264 |
| 119 | MP0004742_abnormal_vestibular_system | 0.88072552 |
| 120 | MP0002090_abnormal_vision | 0.88014624 |
| 121 | MP0003632_abnormal_nervous_system | 0.87800977 |
| 122 | MP0005409_darkened_coat_color | 0.87712919 |
| 123 | MP0001299_abnormal_eye_distance/ | 0.87495910 |
| 124 | MP0010678_abnormal_skin_adnexa | 0.87394784 |
| 125 | MP0005375_adipose_tissue_phenotype | 0.87117716 |
| 126 | MP0003705_abnormal_hypodermis_morpholog | 0.86897741 |
| 127 | MP0000013_abnormal_adipose_tissue | 0.85242211 |
| 128 | MP0005666_abnormal_adipose_tissue | 0.84945173 |
| 129 | MP0002229_neurodegeneration | 0.84373363 |
| 130 | MP0002295_abnormal_pulmonary_circulatio | 0.83655389 |
| 131 | MP0002009_preneoplasia | 0.82854040 |
| 132 | MP0003045_fibrosis | 0.80617266 |
| 133 | MP0008874_decreased_physiological_sensi | 0.80107672 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.80007561 |
| 135 | MP0002971_abnormal_brown_adipose | 0.79575459 |
| 136 | MP0001958_emphysema | 0.79372562 |
| 137 | MP0001485_abnormal_pinna_reflex | 0.77723046 |
| 138 | MP0001944_abnormal_pancreas_morphology | 0.76965029 |
| 139 | MP0004272_abnormal_basement_membrane | 0.76560800 |
| 140 | MP0002168_other_aberrant_phenotype | 0.75965666 |
| 141 | MP0000747_muscle_weakness | 0.75708337 |
| 142 | MP0009763_increased_sensitivity_to | 0.75260712 |
| 143 | MP0001663_abnormal_digestive_system | 0.74585102 |
| 144 | MP0000371_diluted_coat_color | 0.73518076 |
| 145 | MP0003633_abnormal_nervous_system | 0.72675266 |
| 146 | MP0005376_homeostasis/metabolism_phenot | 0.72528592 |
| 147 | MP0009384_cardiac_valve_regurgitation | 0.72471924 |
| 148 | MP0002877_abnormal_melanocyte_morpholog | 0.72074121 |
| 149 | MP0002876_abnormal_thyroid_physiology | 0.71778229 |
| 150 | MP0003172_abnormal_lysosome_physiology | 0.71513671 |
| 151 | MP0005621_abnormal_cell_physiology | 0.70549120 |
| 152 | MP0000249_abnormal_blood_vessel | 0.70280487 |
| 153 | MP0001346_abnormal_lacrimal_gland | 0.69918166 |
| 154 | MP0000230_abnormal_systemic_arterial | 0.69917362 |
| 155 | MP0005334_abnormal_fat_pad | 0.69777711 |
| 156 | MP0000778_abnormal_nervous_system | 0.69650421 |
| 157 | MP0001177_atelectasis | 0.68031800 |
| 158 | MP0008004_abnormal_stomach_pH | 0.66136153 |
| 159 | MP0001915_intracranial_hemorrhage | 0.65607426 |
| 160 | MP0003631_nervous_system_phenotype | 0.65290413 |
| 161 | MP0005076_abnormal_cell_differentiation | 0.64433437 |
| 162 | MP0004510_myositis | 0.63692983 |
| 163 | MP0010386_abnormal_urinary_bladder | 0.63162275 |
| 164 | MP0003950_abnormal_plasma_membrane | 0.63105791 |
| 165 | MP0005448_abnormal_energy_balance | 0.62374633 |
| 166 | MP0009765_abnormal_xenobiotic_induced | 0.60528846 |
| 167 | MP0001486_abnormal_startle_reflex | 0.60459292 |
| 168 | MP0009642_abnormal_blood_homeostasis | 0.60334713 |
| 169 | MP0000639_abnormal_adrenal_gland | 0.59779986 |
| 170 | MP0003959_abnormal_lean_body | 0.59382551 |
| 171 | MP0003183_abnormal_peptide_metabolism | 0.59230922 |
| 172 | MP0003453_abnormal_keratinocyte_physiol | 0.59230670 |
| 173 | MP0003953_abnormal_hormone_level | 0.58897833 |
| 174 | MP0010307_abnormal_tumor_latency | 0.58669528 |
| 175 | MP0002693_abnormal_pancreas_physiology | 0.55444164 |
| 176 | MP0004264_abnormal_extraembryonic_tissu | 0.55165181 |
| 177 | MP0000538_abnormal_urinary_bladder | 0.54406648 |
| 178 | MP0002254_reproductive_system_inflammat | 0.53706126 |
| 179 | MP0010234_abnormal_vibrissa_follicle | 0.52665499 |
| 180 | MP0005379_endocrine/exocrine_gland_phen | 0.52413600 |
| 181 | MP0005248_abnormal_Harderian_gland | 0.52357111 |
| 182 | MP0000647_abnormal_sebaceous_gland | 0.52129461 |
| 183 | MP0005670_abnormal_white_adipose | 0.51892180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 6.58727398 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.40555872 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.02456857 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.92763736 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.88372711 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.79007950 |
| 7 | T lymphocytopenia (HP:0005403) | 4.49536161 |
| 8 | Deep venous thrombosis (HP:0002625) | 4.48774583 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 4.32000354 |
| 10 | Xanthomatosis (HP:0000991) | 4.26230864 |
| 11 | Abnormality of T cell number (HP:0011839) | 4.16218224 |
| 12 | Myositis (HP:0100614) | 4.04445841 |
| 13 | Microcytic anemia (HP:0001935) | 3.96041372 |
| 14 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.91415556 |
| 15 | Orchitis (HP:0100796) | 3.87358923 |
| 16 | Gingival bleeding (HP:0000225) | 3.87262047 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.86093295 |
| 18 | Optic neuritis (HP:0100653) | 3.86093295 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.83783865 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.80454878 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.62042360 |
| 22 | Slow saccadic eye movements (HP:0000514) | 3.61278523 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.60092986 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.59347354 |
| 25 | Hypochromic anemia (HP:0001931) | 3.56551046 |
| 26 | Ketosis (HP:0001946) | 3.56394801 |
| 27 | Prolonged bleeding time (HP:0003010) | 3.56043902 |
| 28 | Gingivitis (HP:0000230) | 3.50415897 |
| 29 | Recurrent skin infections (HP:0001581) | 3.49616394 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 3.43094702 |
| 31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.36820454 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.32747566 |
| 33 | Ketoacidosis (HP:0001993) | 3.32375732 |
| 34 | Hypoglycemic seizures (HP:0002173) | 3.28931777 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.25867369 |
| 36 | Prolonged partial thromboplastin time (HP:0003645) | 3.25617603 |
| 37 | Stomatitis (HP:0010280) | 3.20674921 |
| 38 | Cerebral inclusion bodies (HP:0100314) | 3.13903103 |
| 39 | Peritonitis (HP:0002586) | 3.13662018 |
| 40 | Postural instability (HP:0002172) | 3.11076510 |
| 41 | Epistaxis (HP:0000421) | 3.10259869 |
| 42 | Epidermoid cyst (HP:0200040) | 3.10234396 |
| 43 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.09294884 |
| 44 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.09294884 |
| 45 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.09123636 |
| 46 | Complement deficiency (HP:0004431) | 3.07688965 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.03997002 |
| 48 | Recurrent cutaneous fungal infections (HP:0011370) | 3.03997002 |
| 49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.02871923 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 3.00862352 |
| 51 | Abnormality of the common coagulation pathway (HP:0010990) | 2.93127508 |
| 52 | Recurrent viral infections (HP:0004429) | 2.92962605 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.92444565 |
| 54 | Meningitis (HP:0001287) | 2.90312747 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.89662363 |
| 56 | Hypobetalipoproteinemia (HP:0003563) | 2.88890203 |
| 57 | Leukocytosis (HP:0001974) | 2.87283828 |
| 58 | Vasculitis (HP:0002633) | 2.85693708 |
| 59 | Urticaria (HP:0001025) | 2.84873607 |
| 60 | Visual hallucinations (HP:0002367) | 2.84606085 |
| 61 | Encephalitis (HP:0002383) | 2.83237932 |
| 62 | Abnormality of T cells (HP:0002843) | 2.83118936 |
| 63 | Increased circulating renin level (HP:0000848) | 2.83022198 |
| 64 | Fat malabsorption (HP:0002630) | 2.79098537 |
| 65 | Chest pain (HP:0100749) | 2.77796753 |
| 66 | Hypokalemic alkalosis (HP:0001949) | 2.77681324 |
| 67 | Arterial thrombosis (HP:0004420) | 2.76989573 |
| 68 | Keratoconjunctivitis (HP:0001096) | 2.76301529 |
| 69 | Cellulitis (HP:0100658) | 2.73611470 |
| 70 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.72421869 |
| 71 | Abnormality of glycine metabolism (HP:0010895) | 2.72421869 |
| 72 | Mediastinal lymphadenopathy (HP:0100721) | 2.70545195 |
| 73 | Abnormality of the corticospinal tract (HP:0002492) | 2.70175249 |
| 74 | Abnormality of the fingertips (HP:0001211) | 2.68337751 |
| 75 | Obstructive lung disease (HP:0006536) | 2.67854859 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67854859 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.66667785 |
| 78 | Abnormality of the intrinsic pathway (HP:0010989) | 2.65662190 |
| 79 | Subacute progressive viral hepatitis (HP:0006572) | 2.65355130 |
| 80 | Polycythemia (HP:0001901) | 2.63769052 |
| 81 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.62703870 |
| 82 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.62145423 |
| 83 | Pustule (HP:0200039) | 2.61939087 |
| 84 | Hyperammonemia (HP:0001987) | 2.56497306 |
| 85 | Symptomatic seizures (HP:0011145) | 2.54184958 |
| 86 | Gastrointestinal inflammation (HP:0004386) | 2.53062069 |
| 87 | Abnormal gallbladder morphology (HP:0012437) | 2.50782657 |
| 88 | Acanthocytosis (HP:0001927) | 2.47594463 |
| 89 | Hyperbilirubinemia (HP:0002904) | 2.43366174 |
| 90 | Gout (HP:0001997) | 2.43318585 |
| 91 | Osteomyelitis (HP:0002754) | 2.42724640 |
| 92 | Intention tremor (HP:0002080) | 2.41178767 |
| 93 | Hyperglycinemia (HP:0002154) | 2.39454486 |
| 94 | Abnormality of purine metabolism (HP:0004352) | 2.39052981 |
| 95 | Abnormal platelet volume (HP:0011876) | 2.36951439 |
| 96 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.36711698 |
| 97 | Colitis (HP:0002583) | 2.36463895 |
| 98 | Viral hepatitis (HP:0006562) | 2.35046871 |
| 99 | Hypolipoproteinemia (HP:0010981) | 2.33268456 |
| 100 | Sensory axonal neuropathy (HP:0003390) | 2.33107606 |
| 101 | Skin nodule (HP:0200036) | 2.31412061 |
| 102 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30070248 |
| 103 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.29401112 |
| 104 | Alkalosis (HP:0001948) | 2.28584476 |
| 105 | Abnormality of methionine metabolism (HP:0010901) | 2.27942965 |
| 106 | Hyperglycinuria (HP:0003108) | 2.27758178 |
| 107 | Cholelithiasis (HP:0001081) | 2.27320149 |
| 108 | Metabolic alkalosis (HP:0200114) | 2.26908860 |
| 109 | Recurrent bronchitis (HP:0002837) | 2.25029888 |
| 110 | Eosinophilia (HP:0001880) | 2.24522210 |
| 111 | Hemorrhage of the eye (HP:0011885) | 2.24082739 |
| 112 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.23984955 |
| 113 | Papillary thyroid carcinoma (HP:0002895) | 2.23800669 |
| 114 | Hypoalphalipoproteinemia (HP:0003233) | 2.23384045 |
| 115 | Granulocytopenia (HP:0001913) | 2.23304361 |
| 116 | Hemoptysis (HP:0002105) | 2.22548274 |
| 117 | Periodontitis (HP:0000704) | 2.22362682 |
| 118 | Turricephaly (HP:0000262) | 2.21194313 |
| 119 | Conjunctival telangiectasia (HP:0000524) | 2.19736766 |
| 120 | Anorexia (HP:0002039) | 2.18702990 |
| 121 | Joint hemorrhage (HP:0005261) | 2.18413639 |
| 122 | Pulmonary infiltrates (HP:0002113) | 2.17813226 |
| 123 | Hypochromic microcytic anemia (HP:0004840) | 2.15254196 |
| 124 | Orthostatic hypotension (HP:0001278) | 2.14257460 |
| 125 | Insidious onset (HP:0003587) | 2.13371094 |
| 126 | Termporal pattern (HP:0011008) | 2.13371094 |
| 127 | Episodic fever (HP:0001954) | 2.13346242 |
| 128 | Poikilocytosis (HP:0004447) | 2.12959209 |
| 129 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.12111105 |
| 130 | Hypophosphatemic rickets (HP:0004912) | 2.11854038 |
| 131 | Protuberant abdomen (HP:0001538) | 2.11850151 |
| 132 | Pulmonary embolism (HP:0002204) | 2.11384549 |
| 133 | Rickets (HP:0002748) | 2.09069708 |
| 134 | Resting tremor (HP:0002322) | 2.08873444 |
| 135 | Acute hepatic failure (HP:0006554) | 2.06058715 |
| 136 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.05757695 |
| 137 | Abnormality of the peritoneum (HP:0002585) | 2.05132479 |
| 138 | Delayed CNS myelination (HP:0002188) | 2.03405868 |
| 139 | Hypoplasia of the thymus (HP:0000778) | 2.03293974 |
| 140 | Autoimmune hemolytic anemia (HP:0001890) | 2.02747669 |
| 141 | Ileus (HP:0002595) | 2.02427777 |
| 142 | Increased mean platelet volume (HP:0011877) | 2.01602439 |
| 143 | Difficulty running (HP:0009046) | 2.01361382 |
| 144 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.00964276 |
| 145 | Onion bulb formation (HP:0003383) | 2.00743671 |
| 146 | Hepatocellular carcinoma (HP:0001402) | 2.00485383 |
| 147 | Cerebral hemorrhage (HP:0001342) | 1.99889716 |
| 148 | Back pain (HP:0003418) | 1.99128912 |
| 149 | Supranuclear gaze palsy (HP:0000605) | 1.98938492 |
| 150 | Steatorrhea (HP:0002570) | 1.98269102 |
| 151 | Hyperactive renin-angiotensin system (HP:0000841) | 1.96438843 |
| 152 | Abnormality of eosinophils (HP:0001879) | 1.96177362 |
| 153 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.95204171 |
| 154 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.95204171 |
| 155 | Abnormality of complement system (HP:0005339) | 1.95181225 |
| 156 | Toxemia of pregnancy (HP:0100603) | 1.94672079 |
| 157 | Hypercholesterolemia (HP:0003124) | 1.94458935 |
| 158 | Hydroxyprolinuria (HP:0003080) | 1.94405700 |
| 159 | Abnormality of proline metabolism (HP:0010907) | 1.94405700 |
| 160 | Panhypogammaglobulinemia (HP:0003139) | 1.94305737 |
| 161 | Hyperglycemia (HP:0003074) | 1.94194043 |
| 162 | Irritability (HP:0000737) | 1.93739650 |
| 163 | Lymphopenia (HP:0001888) | 1.92626570 |
| 164 | Vascular calcification (HP:0004934) | 1.92490826 |
| 165 | Papilloma (HP:0012740) | 1.91542989 |
| 166 | Verrucae (HP:0200043) | 1.91542989 |
| 167 | Metabolic acidosis (HP:0001942) | 1.90755188 |
| 168 | Abnormality of renin-angiotensin system (HP:0000847) | 1.89220772 |
| 169 | Cholecystitis (HP:0001082) | 1.88861092 |
| 170 | Abnormal gallbladder physiology (HP:0012438) | 1.88861092 |
| 171 | Abnormality of the gallbladder (HP:0005264) | 1.87700225 |
| 172 | Amyloidosis (HP:0011034) | 1.87584492 |
| 173 | Menorrhagia (HP:0000132) | 1.87226456 |
| 174 | Enlarged kidneys (HP:0000105) | 1.86244215 |
| 175 | Spastic gait (HP:0002064) | 1.85347492 |
| 176 | Hypomagnesemia (HP:0002917) | 1.85343447 |
| 177 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.82164553 |
| 178 | Pheochromocytoma (HP:0002666) | 1.82075590 |
| 179 | Peripheral demyelination (HP:0011096) | 1.81424412 |
| 180 | Increased IgE level (HP:0003212) | 1.80438856 |
| 181 | Axonal loss (HP:0003447) | 1.80277770 |
| 182 | Spastic paraparesis (HP:0002313) | 1.80262545 |
| 183 | Hematochezia (HP:0002573) | 1.79472067 |
| 184 | Fatigue (HP:0012378) | 1.79320323 |
| 185 | Generalized aminoaciduria (HP:0002909) | 1.78528622 |
| 186 | Abnormality of T cell physiology (HP:0011840) | 1.78334934 |
| 187 | Hypokalemia (HP:0002900) | 1.77571471 |
| 188 | Thrombophlebitis (HP:0004418) | 1.76246449 |
| 189 | Cardiovascular calcification (HP:0011915) | 1.76152309 |
| 190 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.76101690 |
| 191 | Akinesia (HP:0002304) | 1.75785617 |
| 192 | IgM deficiency (HP:0002850) | 1.71099805 |
| 193 | Acne (HP:0001061) | 1.66811766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.46595215 |
| 2 | RIPK4 | 3.99176039 |
| 3 | EPHB1 | 3.42898664 |
| 4 | WNK4 | 3.26432530 |
| 5 | OXSR1 | 3.19354874 |
| 6 | MAP2K3 | 3.14754278 |
| 7 | GRK6 | 3.12691608 |
| 8 | INSRR | 2.96978798 |
| 9 | BLK | 2.63445376 |
| 10 | MAP4K1 | 2.44629868 |
| 11 | FGFR2 | 2.39449223 |
| 12 | MET | 2.35925751 |
| 13 | IKBKE | 2.17410024 |
| 14 | SIK1 | 2.12467005 |
| 15 | CSK | 2.10124848 |
| 16 | PRPF4B | 2.08912032 |
| 17 | TAOK3 | 2.03013922 |
| 18 | BCKDK | 2.02684654 |
| 19 | TAOK1 | 2.01095692 |
| 20 | MAP3K2 | 1.99442099 |
| 21 | TYK2 | 1.93244722 |
| 22 | SGK2 | 1.91307766 |
| 23 | NTRK1 | 1.90415768 |
| 24 | FES | 1.90388979 |
| 25 | PTK2B | 1.90383293 |
| 26 | ICK | 1.86401517 |
| 27 | SYK | 1.80736867 |
| 28 | IRAK4 | 1.80684964 |
| 29 | JAK3 | 1.77724255 |
| 30 | MAP3K3 | 1.74869025 |
| 31 | PKN1 | 1.72554203 |
| 32 | STK4 | 1.69964958 |
| 33 | WNK1 | 1.63939363 |
| 34 | TRIB3 | 1.56639917 |
| 35 | BTK | 1.56438669 |
| 36 | BCR | 1.54183590 |
| 37 | FGFR3 | 1.51719396 |
| 38 | ZAP70 | 1.46171993 |
| 39 | PAK3 | 1.44119231 |
| 40 | UHMK1 | 1.42097571 |
| 41 | LATS1 | 1.41565896 |
| 42 | GRK5 | 1.40049065 |
| 43 | SGK494 | 1.40043119 |
| 44 | SGK223 | 1.40043119 |
| 45 | TXK | 1.38901774 |
| 46 | FGFR4 | 1.37627825 |
| 47 | HCK | 1.37422120 |
| 48 | ERBB4 | 1.36914088 |
| 49 | MAP3K11 | 1.35842830 |
| 50 | WNK3 | 1.32152959 |
| 51 | PIM1 | 1.28911860 |
| 52 | TYRO3 | 1.28037909 |
| 53 | PTK2 | 1.27077571 |
| 54 | MAP3K14 | 1.25477485 |
| 55 | JAK1 | 1.25179798 |
| 56 | ERN1 | 1.24623383 |
| 57 | MAPK15 | 1.24269078 |
| 58 | FRK | 1.22757837 |
| 59 | YES1 | 1.20026221 |
| 60 | IRAK2 | 1.19551711 |
| 61 | CAMK1G | 1.19202204 |
| 62 | TAOK2 | 1.18631728 |
| 63 | PTK6 | 1.17597316 |
| 64 | MARK1 | 1.16052874 |
| 65 | MAP3K13 | 1.15219932 |
| 66 | MARK3 | 1.14975680 |
| 67 | PDGFRA | 1.14543830 |
| 68 | BMPR2 | 1.11985207 |
| 69 | RET | 1.09160572 |
| 70 | LYN | 1.08004504 |
| 71 | TRPM7 | 1.07941968 |
| 72 | CAMK1D | 1.07891435 |
| 73 | CSNK1A1L | 1.05596127 |
| 74 | ITK | 1.03521088 |
| 75 | MST1R | 1.01841700 |
| 76 | NLK | 1.01794395 |
| 77 | CDK12 | 1.01732207 |
| 78 | MAP3K10 | 1.00339960 |
| 79 | TNK2 | 0.99305527 |
| 80 | TNIK | 0.98112723 |
| 81 | TEC | 0.97765462 |
| 82 | PAK6 | 0.94303148 |
| 83 | GSK3A | 0.89937825 |
| 84 | LCK | 0.88586165 |
| 85 | MAP3K6 | 0.88386640 |
| 86 | PLK2 | 0.88318500 |
| 87 | KSR2 | 0.87357377 |
| 88 | CSNK1G2 | 0.86967048 |
| 89 | CSNK1G3 | 0.85141094 |
| 90 | IRAK1 | 0.84907594 |
| 91 | KSR1 | 0.83690653 |
| 92 | PRKCH | 0.82931082 |
| 93 | MAP2K2 | 0.82927054 |
| 94 | MAPKAPK5 | 0.81641437 |
| 95 | PRKD3 | 0.81625396 |
| 96 | PBK | 0.81454496 |
| 97 | STK38 | 0.81316452 |
| 98 | FGR | 0.80957798 |
| 99 | DDR2 | 0.80394532 |
| 100 | MAP3K5 | 0.80246218 |
| 101 | CSNK1G1 | 0.80053711 |
| 102 | PDGFRB | 0.80035245 |
| 103 | PHKG2 | 0.78757752 |
| 104 | PHKG1 | 0.78757752 |
| 105 | PRKD1 | 0.78501982 |
| 106 | BMX | 0.77700843 |
| 107 | STK11 | 0.76616194 |
| 108 | PKN2 | 0.75941882 |
| 109 | PDK1 | 0.75778721 |
| 110 | LRRK2 | 0.75070677 |
| 111 | CAMKK2 | 0.74648568 |
| 112 | DYRK1A | 0.74553835 |
| 113 | CAMK2B | 0.73892329 |
| 114 | CAMK2D | 0.73177248 |
| 115 | RIPK1 | 0.71604684 |
| 116 | PDPK1 | 0.71490287 |
| 117 | MATK | 0.70431473 |
| 118 | HIPK2 | 0.70302811 |
| 119 | EIF2AK1 | 0.68619158 |
| 120 | ROCK2 | 0.67114310 |
| 121 | DYRK1B | 0.66962476 |
| 122 | IKBKB | 0.66661897 |
| 123 | ERBB2 | 0.66422410 |
| 124 | MAP3K7 | 0.65692643 |
| 125 | ACVR1B | 0.65283862 |
| 126 | LIMK1 | 0.63779849 |
| 127 | MAP3K1 | 0.63725227 |
| 128 | DAPK2 | 0.63662942 |
| 129 | CDK5 | 0.62960315 |
| 130 | PIK3CG | 0.62331433 |
| 131 | ABL2 | 0.61662994 |
| 132 | ROCK1 | 0.60956182 |
| 133 | RAF1 | 0.60687695 |
| 134 | TBK1 | 0.60467963 |
| 135 | CSF1R | 0.60168947 |
| 136 | PRKAA1 | 0.59876498 |
| 137 | CAMK2G | 0.59138781 |
| 138 | MAP2K4 | 0.58544661 |
| 139 | JAK2 | 0.56786371 |
| 140 | MARK2 | 0.56738175 |
| 141 | PRKAA2 | 0.56335261 |
| 142 | MAP2K1 | 0.55755974 |
| 143 | SCYL2 | 0.55172324 |
| 144 | NEK6 | 0.55015650 |
| 145 | FER | 0.54275024 |
| 146 | STK10 | 0.52519571 |
| 147 | DMPK | 0.50678907 |
| 148 | CAMK4 | 0.50173829 |
| 149 | LMTK2 | 0.47927647 |
| 150 | PRKCQ | 0.47916784 |
| 151 | PRKACG | 0.47856391 |
| 152 | FYN | 0.47222974 |
| 153 | PRKCZ | 0.46795598 |
| 154 | MAPK12 | 0.46683565 |
| 155 | PRKCE | 0.45342161 |
| 156 | AKT3 | 0.45269778 |
| 157 | CHUK | 0.45023235 |
| 158 | TGFBR2 | 0.43179916 |
| 159 | KIT | 0.42677419 |
| 160 | CAMK2A | 0.42265184 |
| 161 | SGK3 | 0.41978454 |
| 162 | TIE1 | 0.41381211 |
| 163 | SGK1 | 0.38110203 |
| 164 | EPHA3 | 0.38048496 |
| 165 | MST4 | 0.36673598 |
| 166 | FGFR1 | 0.36024396 |
| 167 | CDC42BPA | 0.35505607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13310605 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.81238398 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.72493630 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71735253 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.63536552 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.55582238 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.55092298 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.52397183 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.43894868 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.36366547 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36080733 |
| 12 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.30137886 |
| 13 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.29205102 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.26386102 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.19181400 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.16205719 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.14772294 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.10506430 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.00785134 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.00741154 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99234726 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.95651324 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94803134 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.94388318 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.93434521 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.89802105 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.81800067 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.78874116 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.78852917 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.74369848 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.73968426 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70289281 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.67469243 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.65266379 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61954664 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.59965393 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59945462 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59665877 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.59125654 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59048023 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.58625437 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.54519045 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54494042 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53507620 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.52960318 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49999924 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.48648492 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.44084696 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 1.40100459 |
| 50 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.38425314 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38349061 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.37782518 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36234747 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.35194942 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.32654534 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.32606774 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.32526320 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30113174 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.27669706 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 1.26841897 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 1.26115636 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24724859 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24717384 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.24066087 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.23067666 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22567580 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.22114420 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21659198 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 1.18622356 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 1.16244909 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15714728 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.14437052 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14022349 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.13299734 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11373482 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10502804 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10073591 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09789986 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09450660 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 1.08248898 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07981272 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.07205786 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05328525 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01747961 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01396747 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01343936 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00369132 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.98914938 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98886247 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.98416282 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98283667 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95780003 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95625018 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95027726 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93201058 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.92590668 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92364796 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.88957014 |
| 99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85670578 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85414530 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85304996 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.85251736 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83592516 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82883200 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81749515 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80676607 |
| 107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80522984 |
| 108 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80115264 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79487938 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79004795 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76723191 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76696343 |
| 113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76500956 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76237496 |
| 115 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75316500 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74818936 |
| 117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74678881 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.73262732 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72648678 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.71927323 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68800646 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.68685615 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67438674 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66756320 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66755037 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65428236 |
| 127 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63984714 |
| 128 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63857422 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62047566 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.59605424 |
| 131 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59199880 |
| 132 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58297227 |
| 133 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57870931 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57826082 |
| 135 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56549764 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.54808141 |
| 137 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54572474 |
| 138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54149279 |
| 139 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53203733 |
| 140 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52090928 |
| 141 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51472206 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.50625645 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50360822 |
| 144 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.50021227 |
| 145 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49613948 |
| 146 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48896500 |
| 147 | Shigellosis_Homo sapiens_hsa05131 | 0.48744324 |
| 148 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47792806 |
| 149 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47689217 |
| 150 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47043514 |
| 151 | Protein export_Homo sapiens_hsa03060 | 0.47019134 |
| 152 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46021317 |
| 153 | Insulin resistance_Homo sapiens_hsa04931 | 0.45931159 |
| 154 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45108045 |
| 155 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45048978 |
| 156 | Insulin secretion_Homo sapiens_hsa04911 | 0.43703706 |
| 157 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43307084 |
| 158 | Amoebiasis_Homo sapiens_hsa05146 | 0.43105743 |
| 159 | Pertussis_Homo sapiens_hsa05133 | 0.43015544 |
| 160 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42750248 |
| 161 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42645812 |
| 162 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42577580 |
| 163 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42535719 |
| 164 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40617896 |
| 165 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39871971 |
| 166 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39609623 |
| 167 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38962101 |
| 168 | Mineral absorption_Homo sapiens_hsa04978 | 0.38552698 |
| 169 | Axon guidance_Homo sapiens_hsa04360 | 0.38159829 |
| 170 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36359314 |
| 171 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35571585 |
| 172 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35293533 |
| 173 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.34876755 |
| 174 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34451300 |
| 175 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30511304 |
| 176 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.26721212 |
| 177 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.26678042 |
| 178 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25760960 |
| 179 | GABAergic synapse_Homo sapiens_hsa04727 | 0.25582563 |
| 180 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25097658 |
| 181 | Cocaine addiction_Homo sapiens_hsa05030 | 0.23894197 |
| 182 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.23610414 |
| 183 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.23602953 |
| 184 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23216390 |
| 185 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.21103750 |
| 186 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.20538904 |
| 187 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.19851727 |
| 188 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17481281 |

